Study evaluates mpact of New Guidelines on Cesarean Delivery Rates

The increasing prevalence of cesarean deliveries remains a challenge in modern obstetrics. In 2012 and 2014, updated recommendations for reducing cesarean deliveries among first-time mothers were introduced by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Society for Maternal-Fetal Medicine, and the American College of Obstetricians and Gynecologists. Recent study was a cluster randomized controlled trial conducted in 26 Canadian hospitals to assess whether the adoption of new guidelines for diagnosing nonprogressing labor would reduce cesarean delivery rates in nulliparous women.

Study Design and Outcomes

The study included 13 control sites and 13 intervention sites. The primary outcome was the rate of cesarean delivery, and secondary outcomes included spontaneous vaginal birth and maternal and neonatal safety.

Analysis and Findings

The analysis was based on 45,193 deliveries at intervention sites and 43,725 deliveries at control sites. The study found no evidence of a decrease in the rate of cesarean delivery associated with the intervention. However, a slight increase in the rate of spontaneous vaginal delivery was observed in the intervention group, with no differences in adverse maternal or neonatal outcomes.

Site-Specific Variation and Compliance

The researchers observed site-specific variation in the effectiveness of the guidelines on the cesarean delivery rate. They noted that compliance with the guidelines at the intervention sites was low (31%), which may account for the null results. However, compliance was higher at sites with a reduction in cesarean delivery and an increase in spontaneous vaginal delivery.

Conclusion and Implications

The study contributes important information to the challenge of reducing cesarean delivery rates. While the intervention did not result in a statistically significant reduction in cesarean deliveries, the safety data and the slight increase in spontaneous vaginal births suggest that this approach deserves further study, particularly in settings where compliance with the guidelines can be improved.

Key Points

Here are the 6 key points from the research paper:

1. This was a cluster randomized controlled trial conducted in 26 Canadian hospitals to assess whether the adoption of new guidelines for diagnosing nonprogressing labor would reduce cesarean delivery rates in nulliparous women.

2. The primary outcome was the rate of cesarean delivery, and secondary outcomes included spontaneous vaginal birth and maternal and neonatal safety.

3. The study found no evidence of a decrease in the rate of cesarean delivery associated with the intervention, but did observe a slight increase in the rate of spontaneous vaginal delivery in the intervention group, with no differences in adverse maternal or neonatal outcomes.

4. The researchers observed site-specific variation in the effectiveness of the guidelines on the cesarean delivery rate, and noted that compliance with the guidelines at the intervention sites was low (31%), which may account for the null results. However, compliance was higher at sites with a reduction in cesarean delivery and an increase in spontaneous vaginal delivery.

5. The study contributes important information to the challenge of reducing cesarean delivery rates, and suggests that this approach deserves further study, particularly in settings where compliance with the guidelines can be improved.

6. While the intervention did not result in a statistically significant reduction in cesarean deliveries, the safety data and the slight increase in spontaneous vaginal births indicate that this approach warrants additional investigation.

Reference –

Wood S, Skiffington J, Brant R, Crawford S, Hicks M, Mohammad K, Mrklas KJ, Tang S, Metcalfe A; REDUCED Trial Team. The REDUCED trial: a cluster randomized trial for REDucing the utilization of CEsarean delivery for dystocia. Am J Obstet Gynecol. 2023 May;228(5S):S1095-S1103. doi: 10.1016/j.ajog.2022.10.038. Epub 2023 Mar 16. PMID: 37164490.

Powered by WPeMatico

Levonorgestrel-Releasing Intrauterine Systems linked to Increased Breast Cancer Risk: JAMA

Denmark: A research letter published in JAMA indicates that the use of a levonorgestrel-releasing intrauterine system for pregnancy prevention is associated with an increased risk of breast cancer among women aged 15 to 49 in Denmark.

“Users of the levonorgestrel-releasing intrauterine system faced a higher risk of breast cancer compared to nonusers, with this risk increasing further with the number of years of use,” the researchers wrote.

The use of levonorgestrel-releasing intrauterine systems (LNG-IUSs) has been on the rise, becoming the preferred hormonal contraceptive among Danish premenopausal women over 30. However, the association between LNG-IUS use and breast cancer risk remains uncertain. While some studies have indicated an increased risk of breast cancer among LNG-IUS users, these studies did not specifically address the duration of continuous use or adequately consider other hormonal contraceptive methods.

In light of this, Lina Steinrud Mørch, Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark, and colleagues aimed to evaluate the breast cancer risk associated with prolonged LNG-IUS use while accounting for other hormonal exposures.

For this purpose, the researchers conducted a nationwide study utilizing data from Danish registries, focusing on 78,595 first-time initiators of levonorgestrel-releasing intrauterine systems at doses of 52 mg, 19.5 mg, and 13.5 mg between 2000 and 2019. They matched women using the intrauterine system with those who did not use hormonal contraceptives, following all participants until the diagnosis of breast cancer, other cancers, pregnancy, initiation of postmenopausal hormone therapy, emigration, death, or December 2022.

The study revealed the following findings:

  • During a mean follow-up of 6.8 years, 1,617 participants had a breast cancer diagnosis, of whom 720 were levonorgestrel-releasing intrauterine system users.
  • Levonorgestrel-releasing intrauterine system users had an increased risk for breast cancer compared with hormonal contraceptive nonusers (HR = 1.4).
  • Breast cancer risk increased along with years of use for women who used levonorgestrel-releasing intrauterine systems for 0 to 5 years (HR = 1.3), more than 5 to 10 years (HR = 1.4), and more than 10 to 15 years (HR = 1.8).
  • Per 10,000 users, the increased breast cancer risk corresponding to years of use resulted in an excess of 14 breast cancer diagnoses for 0 to 5 years, 29 diagnoses for more than 5 to 10 years, and 71 diagnoses for more than 10 to 15 years.

The researchers noted, “While the absolute risk of breast cancer is low among young women, the study identified an excess risk of 14 cases per 10,000 females. Importantly, this risk did not increase with the duration of levonorgestrel-releasing intrauterine system use. Given the rising use of levonorgestrel-releasing intrauterine systems among women at an age where there is some risk for breast cancer, and the likelihood of long-term use, discussions about the benefits and risks must include information regarding breast cancer risk.”

Reference:

Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. Published online October 16, 2024. doi:10.1001/jama.2024.18575

Powered by WPeMatico

Autoimmune disorders in women linked with premature ovarian insufficiency, reveals research

A new study published in the journal of Human Reproduction showed that women confirmed to have premature ovarian insufficiency (POI) have an elevated frequency of certain particular autoimmune disorders. 1% of women have spontaneous premature ovarian insufficiency, which is characterized as the loss of ovarian function before the age of 40. The autoimmune processes affecting the ovaries that cause POI might appear alone. Autoimmunity has been proposed as a key player in the pathophysiology of POI. The proportion of POI patients with an autoimmune etiology has been estimated to be between 4% and 50%. Thus, this study by Savukoski and colleagues was to investigate any potential link between severe autoimmune illnesses and early ovarian insufficiency, both before and after the diagnosis of POI.

This community-based registry investigation included both case-control and cohort analysis, where 3972 women with spontaneous POI diagnoses between 1988 and 2017 were involved, along with 15,708 female population controls. Diagnoses of autoimmune diseases were assessed from childhood till the end of 2017. The Finnish Social Insurance Institution’s reimbursement registry data was used to identify women with POI based on their eligibility for hormone replacement treatment (HRT). For every POI instance, 4 female population controls who were matched based on age and place of residence were looked for in order to create a reference cohort. Women who had had a bilateral oophorectomy or a history of malignancy were not eligible. Diagnoses for severe autoimmune disorders from 1970 to 2017 were retrieved from the Hospital Discharge Registry.

When compared to population controls, the frequency of at least one serious autoimmune illness in women with POI was 5.6%, with an OR of 2.6. The women with POI had higher rates of several specific autoimmune diseases like hyperthyroidism, inflammatory bowel diseases, Addison’s disease, systemic lupus erythematosus, vasculitis, sarcoidosis, rheumatoid arthritis, and polyglandular autoimmune diseases prior to the index date.

Also, there was no difference in the prevalence of diabetes type 1 and ankylosing spondylitis between the POI and the reference cohort. Following a diagnosis of post-traumatic inflammation (POI), the odds ratio (SIR) for receiving a new diagnostic of a severe autoimmune illness was 2.8 during the first three years following the diagnosis, and it progressively dropped to 1.3 after 12 years.

Overall, this study gives new evidence at the population level on the relationship between severe autoimmune illnesses and POI. Overall, women with POI have a more than 2-fold higher frequency of serious autoimmune disorders, and this prevalence persists for more than a decade following diagnosis when compared to female population controls.

Reference:

Savukoski, S. M., Silvén, H., Pesonen, P., Pukkala, E., Gissler, M., Suvanto, E., Ollila, M.-M., & Niinimäki, M. (2024). Excess of severe autoimmune diseases in women with premature ovarian insufficiency: a population-based study. In Human Reproduction. Oxford University Press (OUP). https://doi.org/10.1093/humrep/deae213

Powered by WPeMatico

Jammu Hospital fined by Legal Metrology Department for overcharging patients

The Legal Metrology Department (LMD) has taken action against the Punjab-based Jammu private hospital chain based in Jammu at Greater Kailash. The hospital has been fined for using non-standard units of measurement in its transactions, which violates legal regulations.
Through this significant step, LMD aims to protect consumers from fraudulent practices and ensure fair treatment in the healthcare sector.

For more information, click on the link below:

Powered by WPeMatico

NTRUHS Invites Applications for MD, MS Ayurveda courses 2024, Know All admission Details Here

Andhra Pradesh- Dr NTR University of Health Sciences (Dr NTRUHS) is inviting online application forms from eligible candidates for admission to MD and MS (Ayurveda) courses under competent authority quota seats for the academic year 2024-25 in the colleges affiliated with the University. On this, Dr NTRUHS has released a notification detailing the eligibility, registration and tuition fee, documents, and other details.

As per the notification, the online application forms are available on the official website of Dr NTRUHS up to 6.00 P.M on 22 October 2024.

THE REGISTRATION FEE

BAMS Completed Within AP

S.NO

CATEGORY

REGISTRATION FEE INCLUDING 18% GST

TOTAL AMOUNT

1

OC/BC

Rs.5,900/- (5,000/- + 900/- GST 18%)

Rs.5,900/-

2

SC/ST

Rs.4, 956/- (4,200/- + 756/- GST 18%)

Rs.4,956/-

BAMS Completed Outside AP

S.NO

CATEGORY

REGISTRATION FEE INCLUDING 18% GST

IN ADDITION TO THE REGISTRATION & VERIFICATION FEE INCLUDING 18% GST

TOTAL AMOUNT

1

OC/BC

Rs.5,900/- (5,000/- + 900/- GST 18%)

Rs.3,540/- (3,000/- + 540/- GST 18%)

Rs.9,440/-

2

SC/ST

Rs.4, 956/- (4,200/- + 756/- GST 18%)

Rs.3,540/- (3,000/- + 540/- GST 18%)

Rs.8,496/-

PROCEDURE OF FILLING ONLINE APPLICATION FORM

1 The Registration number which will be sent to the registered mobile after entering the basic details, should be noted for further use. The Registration number should be kept confidential and should not be disclosed to others.

2 The candidates should fill – in all the correct details in the online application form and should upload all the requisite documents.

ELIGIBILITY CRITERIA

1 Eligibility criteria for admission into the Postgraduate programme shall be the following, namely-

i A graduate of Ayurvedacharya – Bachelor of Ayurvedic Medicine and Surgery from a recognized Institution.

ii Registered medical practitioner, registered in State or Union territory or Central register.

iii Qualified in Postgraduate National Entrance Test.

2 Along with this, as per the guidelines issued by the Ministry of AYUSH, Govt. of India, the candidates who secured the below-noted minimum marks or above in AIAPGET-2024-25 are only eligible for admission into MD/MS (Ayurveda) courses-

S.NO

NAME OF CATEGORY

QUALIFYING PERCENTILE

MARKS

1

General category (UR/EWS).

50th

123

2

OBC/SC/ST.

40th

106

3

General (UR) Category (EWS/PwBD) Persons with Benchmark Disability.

45th

108

4

OBC (PwBD) Persons with Benchmark Disability.

40th

112

3 The candidate should have completed training as an internee/House Officer on or before 31.07.2024.

4 For in-service candidates, extra weightage of marks on length and type of service will be awarded as on 30.09.2024.

i Rural service – 8% per each year upto a maximum of 3 years.

ii Tribal service – 10% per each year upto a maximum of 3 years.

iii No upper age limit is specified for admission to MD/MS (Ayurveda) Courses.

5 Candidates who were already admitted and studying MD/MS (Ayurveda) Courses should not be permitted for admission into MD/MS (Ayurveda) Courses unless they discontinue the course by remitting the bond amount and the stipend taken up to that date before submitting application form and such candidates should submit the discontinuance certificate issued by the Head of the Institution along with the application.

6 Candidates who are already holding a Post Graduate Degree in MD/MS (Ayurveda) in a subject should not be eligible for admission into MD/MS (Ayurveda) Courses.

MERIT LIST

1 The merit position of the candidates applied should be determined based on AIAPGET-2024-25 Ranks and as per their eligibility.

2 There should be a committee appointed by Dr NTR UHS for the selection of candidates against Competent Authority seats as per the merit list.

TUITION FEE

The selected candidates have to pay tuition fees and other constituent fees, special fees and caution money deposits at the rates laid down for the purpose from time to time subject to the conditions laid therein at the time of admission. The regulations governing the same will be informed. However, the fee can be paid through a Debit card / Credit card or Net Banking.

CERTIFICATES REQUIRED BEFORE FILLING THE APPLICATION FORM ONLINE

The following Certificates are required to complete the application process. The certificates are to be scanned and kept ready to upload. The application fee has to be paid online-

1 AIAPGET – 2024 Rank Card.

2 Birth Certificate (SSC Marks Memo).

3 Provisional or Original BAMS Degree Certificate.

4 BAMS study certificates.

5 Compulsory Rotatory Internship certificate.

6 Permanent (or) Provisional Council Registration Certificate.

7 Transfer Certificate.

8 Caste Certificate, if applicable.

9 Minority Certificate, if applicable.

10 Income and Asset certificates for Economically Weaker Sections (EWS) valid for the year 2024-25 (Financial year 2023-24) issued by the Tahsildars on or after 01-04-2024 pertaining to AP-Non State-wide Institutions.

11 Aadhar Card.

12 Service certificate, if applicable.

13 Local status Certificates issued by MRO of AP (candidates migrated from Telangana to Andhra Pradesh (If Applicable).

14 Candidate’s Latest passport-size Photo.

15 Specimen Signature of the Candidate.

For Non-Local Candidates-

1 Minimum 10 years Study Certificates of Student / either of parents of Andhra Pradesh State, if BAMS is from outside Andhra Pradesh State.

(OR)

2 Minimum 10 years Residence Certificate of Andhra Pradesh State of either of parents.

(OR)

3 Current employment Certificates of either of parents, if working in Andhra Pradesh only.

To view the notification, click the link below

Powered by WPeMatico

RG Kar hospital Protests: Doctors are ‘Soft Targets’, says IMA chief amid ongoing stir

Amid an indefinite hunger strike by young doctors in West Bengal over the rape and murder of a PG doctor at RG Kar Medical College Hospital, Indian Medical Association chief Dr RV Asokan said Doctors have always been ”soft targets” and the ”injustice inflicted on the medical fraternity has no parallel.”
In a statement, posted on X by the IMA, Dr Asokan said on Tuesday that from the word go a doctor in India is a “slave chained by the Bond system”.

For more information, click on the link below:

Powered by WPeMatico

NEET MDS 2024: DME Chhattisgarh issues corrigendum on special stray vacancy round

The Director of Medical Education (DME Chhattisgarh) has issued a corrigendum on online applications for the Special Stray Vacancy Round counseling for the 2024 Postgraduate Dental (MDS) course. This announcement was made via Information No. 9534/Student/Counselling/Sanchishi/2024, dated October 16, 2024, from Raipur. This round of counseling is aimed at filling vacant seats in the MDS program for the upcoming academic year 2024.25.
As per notice, candidates who had previously registered but were unallocated in earlier rounds can participate in the Special Stray Vacancy Round without the need for re-registration. However, it is compulsory for candidates to select both their preferred subject and institute once again on the official online portal. Previous selections of subject and institute will no longer be valid.

For more information, click on the link below:

Powered by WPeMatico

Study finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV—short for respiratory syncytial virus—vaccine. VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023–24 respiratory disease season, the first season after RSV vaccine approval in the U.S.

Powered by WPeMatico

Medicaid ACOs have not yet improved care for kids with asthma, study says

In its first three years of operation, Medicaid’s primary care-focused Accountable Care Organizations (ACOs) in Massachusetts showed “no clear evidence of success” in improving asthma care for children, according to research led by the University of Massachusetts Amherst and UMass Chan Medical School-Baystate Health.

Powered by WPeMatico

How neural networks help the brain predict future events

On 17 October 2024, Martina Lamberti publicly defended her Ph.D. thesis, “Know the Past to See the Future: Memory and Prediction in In-Vitro Cortical Neurons,” at the University of Twente. Her research sheds light on how the brain predicts future events and forms memories. These findings could open new doors in understanding neurological conditions like dementia.

Powered by WPeMatico